Genetic Disorders tests in Dubai & UAE

Compare available Genetic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

136

Listed price range

1,100.00–4,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Disorders test prices

Showing 16–30 of 136 matching tests.

Genetic Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5396 C4orf26 Gene Amelogenesis Imperfecta Type 2A4 Genetic Test This test identifies disease-causing mutations in the C4orf26 gene associated with Amelogenesis Imperfecta Type 2A4.	Whole blood, extracted DNA, dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["C4orf26 gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No special fasting required", "Pre-test genetic counselling session is mandatory"] Indications ["Suspected Amelogenesis Imperfecta Type 2A4", "Hereditary enamel defects"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: K00.5, Z31.430 Clinical summary This test identifies disease-causing mutations in the C4orf26 gene associated with Amelogenesis Imperfecta Type 2A4.
TEST-5576 CCDC40 Gene Analysis (Primary Ciliary Dyskinesia Type 15) Genetic Test This test identifies pathogenic variants in the CCDC40 gene associated with Primary Ciliary Dyskinesia Type 15.	Peripheral whole blood (3–5 mL) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC40 gene sequence", "Copy Number Variations (CNVs) in CCDC40 gene"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history", "Pre-genetic counseling session recommended"] Indications ["Suspected Primary Ciliary Dyskinesia Type 15", "Family history of Primary Ciliary Dyskinesia", "Chronic respiratory symptoms", "Recurrent ear infections", "Infertility investigation"] Measurement technique Confirm with laboratory Codes LOINC: 21665-6 ICD-10: Q34.8 Clinical summary This test identifies pathogenic variants in the CCDC40 gene associated with Primary Ciliary Dyskinesia Type 15.
TEST-5033 CD59 Gene Hemolytic Anemia Genetic Test This test identifies pathogenic variants in the CD59 gene associated with hemolytic anemia and immune-mediated polyneuropathy.	Whole Blood (Peripheral)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CD59 gene", "Molecular cause of CD59-mediated hemolytic anemia"] Parameters [] Preparation ["No fasting required"] Indications ["Clinical suspicion of CD59 deficiency", "Unexplained hemolytic anemia", "Immune-mediated polyneuropathy"] Measurement technique Confirm with laboratory Codes LOINC: 94477-0 ICD-10: D59.8 Clinical summary This test identifies pathogenic variants in the CD59 gene associated with hemolytic anemia and immune-mediated polyneuropathy.
TEST-3745 CDC73 Gene Hyperparathyroidism Type 1, Familial Genetic Test This genetic test identifies mutations in the CDC73 gene associated with Familial Hyperparathyroidism Type 1.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDC73 gene mutations", "Copy number variants in CDC73"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Suspected Familial Hyperparathyroidism Type 1", "Family history of CDC73-related disorders", "Assessment of cancer risk in parathyroid, jaw, and kidneys"] Measurement technique Confirm with laboratory Codes LOINC: 92937-7 ICD-10: E21.0 Clinical summary This genetic test identifies mutations in the CDC73 gene associated with Familial Hyperparathyroidism Type 1.
TEST-5666 CELSR2 Gene Genetic Testing for Schizophrenia Risk Assessment Test This test evaluates the CELSR2 gene for variants associated with an increased risk of developing schizophrenia spectrum disorders.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CELSR2 gene sequence", "Single nucleotide variants (SNVs)", "Small insertions/deletions", "Copy-number alterations", "Regulatory regions of CELSR2"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session required.", "No fasting or medication changes needed.", "Informed consent required."] Indications ["Familial schizophrenia pedigree", "Treatment-resistant psychosis of unclear aetiology", "Differential diagnosis of schizoaffective versus neurodevelopmental disorder", "Pre-symptomatic risk profiling in first-degree relatives"] Measurement technique Confirm with laboratory Codes LOINC: 81409-6 ICD-10: Z13.89 Clinical summary This test evaluates the CELSR2 gene for variants associated with an increased risk of developing schizophrenia spectrum disorders.
TEST-3768 CFHR5 Gene Hemolytic Uremic Syndrome Genetic Test This test identifies pathogenic variants in the CFHR5 gene associated with atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy.	Whole blood (EDTA) or extracted genomic DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CFHR5 gene", "Copy number variations (CNV) in the CFHR5 gene"] Parameters [] Preparation ["No fasting required", "Prior genetic counselling session mandatory to document family history"] Indications ["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Diagnosis of C3 glomerulopathy", "Family risk assessment for aHUS and C3 glomerulopathy"] Measurement technique Confirm with laboratory Codes LOINC: 21673-3 ICD-10: D59.3 Clinical summary This test identifies pathogenic variants in the CFHR5 gene associated with atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy.
TEST-2964 CHM Gene Choroideremia Genetic Test This genetic test analyzes the CHM gene for mutations associated with choroideremia, an inherited eye disorder causing progressive vision loss.	Peripheral whole blood (EDTA) or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHM gene", "Copy Number Variations (CNV) in the CHM gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of suspected choroideremia", "Carrier screening for individuals with a family history", "Family planning for affected families", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92811-6 ICD-10: H31.21 Clinical summary This genetic test analyzes the CHM gene for mutations associated with choroideremia, an inherited eye disorder causing progressive vision loss.
TEST-5217 CHRND Gene Myasthenic Syndrome (Congenital, Type 3B, Fast-Channel) Genetic Test This test evaluates the CHRND gene for mutations associated with Congenital Myasthenic Syndrome type 3B (fast-channel). It identifies specific genetic variants causing the conditio...	Whole blood (EDTA tube), extracted DNA (≥1 µg), or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHRND gene mutations", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications"] Indications ["Suspected Congenital Myasthenic Syndrome type 3B", "Family history of Congenital Myasthenic Syndrome", "Genetic counseling recommended"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G70.2 Clinical summary This test evaluates the CHRND gene for mutations associated with Congenital Myasthenic Syndrome type 3B (fast-channel). It identifies specific genetic variants causing the condition.
TEST-5607 Chromosome 15q11 Gene Analysis for Prader-Willi Syndrome (NGS) Test This test evaluates the chromosome 15q11.2-q13 region for genetic abnormalities associated with Prader-Willi syndrome.	Whole Blood (Peripheral)	3 – 4 Weeks (from sample receipt)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Copy-number variations (deletions/duplications)", "Single-nucleotide variants (SNVs)", "Methylation patterns", "Uniparental disomy (UPD)"] Parameters [] Preparation ["No special preparation is needed.", "Continue all medications as prescribed."] Indications ["Suspected Prader-Willi syndrome based on clinical presentation", "Differential diagnosis of developmental delay and hypotonia", "Prenatal screening if indicated"] Measurement technique Confirm with laboratory Codes LOINC: 49637-7 ICD-10: Q87.1 Clinical summary This test evaluates the chromosome 15q11.2-q13 region for genetic abnormalities associated with Prader-Willi syndrome.
TEST-6114 CLDN19 Gene Hypomagnesemia Type 5 Genetic Test This test identifies mutations in the CLDN19 gene, which are responsible for familial primary hypomagnesemia with renal magnesium wasting (Type 5).	Peripheral whole blood (EDTA tube)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CLDN19 gene mutations", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Individuals with persistently low serum magnesium accompanied by symptoms", "Asymptomatic family members of diagnosed patients"] Measurement technique Confirm with laboratory Codes LOINC: 81342-1 ICD-10: E83.42 Clinical summary This test identifies mutations in the CLDN19 gene, which are responsible for familial primary hypomagnesemia with renal magnesium wasting (Type 5).
TEST-6335 COG8 Gene Glycosylation Disorder Type 2H Genetic Test This test evaluates the COG8 gene for variants associated with Congenital Disorder of Glycosylation Type 2H (CDG-IIh). It identifies single-nucleotide variants, small insertions/de...	Whole Blood (EDTA), FTA Card Spot, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COG8 gene sequence", "Copy Number Variations (CNVs) in COG8 gene"] Parameters [] Preparation ["Do not discontinue any prescribed medication or supplementation without explicit instruction from your treating physician."] Indications ["Suspected Congenital Disorder of Glycosylation Type 2H (CDG-IIh)", "Diagnostic odyssey for developmental delay or hypotonia"] Measurement technique Confirm with laboratory Codes LOINC: 102286-1 ICD-10: E77.8, Z14.8, Z82.79 Clinical summary This test evaluates the COG8 gene for variants associated with Congenital Disorder of Glycosylation Type 2H (CDG-IIh). It identifies single-nucleotide variants, small insertions/deletions, and copy-number alterations across the entire COG8 gene.
TEST-2455 COL11A2 Gene Otospondylomegaepiphyseal Dysplasia Genetic Test This test analyzes the COL11A2 gene for pathogenic variants associated with Otospondylomegaepiphyseal Dysplasia (OSMED). It utilizes Next-Generation Sequencing (NGS) to provide com...	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COL11A2 gene sequence", "Copy Number Variations (CNV) in COL11A2"] Parameters [] Preparation ["No specific fasting required", "Inform clinician of all current medications"] Indications ["Suspected Otospondylomegaepiphyseal Dysplasia (OSMED)", "Family history of OSMED", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q78.8, Z84.1, Z13.79 Clinical summary This test analyzes the COL11A2 gene for pathogenic variants associated with Otospondylomegaepiphyseal Dysplasia (OSMED). It utilizes Next-Generation Sequencing (NGS) to provide comprehensive genetic information.
TEST-4717 COL1A1 Gene Osteogenesis Imperfecta Genetic Test This test analyzes the entire COL1A1 gene using Next Generation Sequencing to identify mutations associated with Osteogenesis Imperfecta.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COL1A1 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected Osteogenesis Imperfecta", "Family history of Osteogenesis Imperfecta", "Need for genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 69548-6 ICD-10: Q78.0, Z14.8, Z31.5 Clinical summary This test analyzes the entire COL1A1 gene using Next Generation Sequencing to identify mutations associated with Osteogenesis Imperfecta.
TEST-5167 COL3A1 Gene Ehlers-Danlos Syndrome Type 3 Genetic Test This genetic test evaluates the COL3A1 gene for mutations associated with vascular Ehlers-Danlos syndrome (vEDS). It identifies pathogenic variants, including single nucleotide var...	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COL3A1 gene sequence", "Copy Number Variants (CNVs) in COL3A1"] Parameters [] Preparation ["No fasting required.", "No medication adjustments required.", "Mandatory genetic counseling session prior to sample collection."] Indications ["Diagnosis of vascular Ehlers-Danlos syndrome", "Family risk assessment for vEDS", "Carrier screening in individuals with a family history of vEDS"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q79.6 Clinical summary This genetic test evaluates the COL3A1 gene for mutations associated with vascular Ehlers-Danlos syndrome (vEDS). It identifies pathogenic variants, including single nucleotide variants (SNVs), insertions/deletions (indels), and copy number variants (CNVs).
TEST-5803 COL4A4 Alport Syndrome Autosomal Recessive Genetic Test This test detects pathogenic variants in the COL4A4 gene associated with Autosomal Recessive Alport Syndrome.	Peripheral Whole Blood, FTA Card, or Extracted DNA	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in COL4A4 gene", "Sensorineural hearing loss", "Progressive kidney disease", "Ocular defects"] Parameters [] Preparation [] Indications ["Confirmation of Alport syndrome diagnosis", "Distinguishing Alport syndrome from other glomerular disorders", "Guiding treatment and surveillance", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 101231-1 ICD-10: Q87.81 Clinical summary This test detects pathogenic variants in the COL4A4 gene associated with Autosomal Recessive Alport Syndrome.

Category overview

Genetic Disorders: overview

Understanding your family's risk for specific hereditary conditions empowers you to make proactive, highly informed health and reproductive decisions. As a core pillar of our advanced Genetics department, comprehensive testing for Genetic Disorders evaluates your DNA for a curated selection of mutations known to cause distinct, multi-system hereditary conditions. Utilizing state-of-the-art sequencing technology, this empowering molecular screening provides the critical clarity needed to assess carrier status and diagnostic risks, safely guiding informed family planning, proactive medical interventions, and specialized reproductive counseling. Widely respected for compassionate diagnostic excellence among premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, uncompromising analytical accuracy, and rapid, dependable reporting. Safeguard your family’s future—book your genetic disorders testing in UAE, arrange a comfortable clinic or home sample collection, or connect with our specialized medical team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.